3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Lymphoma, B-Cell
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematuria
1
Interventions
Cyclophosphamide
3
Peripheral Blood Stem Cell Transplantation
2
pirtobrutinib
1
ibritumomab tiuxetan
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Vincristine
1
Valproic Acid
1
Transplantation
1
Rituximab
1
Positron Emission Tomography Computed Tomography
1
Pneumococcal Vaccines
1
Pemetrexed
1
Mycophenolic Acid
1
Mesenchymal Stem Cell Transplantation
1
Immunohistochemistry
1
Immunoenzyme Techniques
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Exercise
1
Etoposide
1
Cyclosporine
1
Cryotherapy
1
Cord Blood Stem Cell Transplantation
1
CF regimen
1
Busulfan
1
23-valent pneumococcal capsular polysaccharide vaccine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Leukemia, Lymphocytic, Chronic, B-Cell
×
Valproic Acid
×
Clear all
NCT02144623
2017-03-03
PREVAIL
Lund University Hospital
Phase EARLY_PHASE1
Completed
4 enrolled